Nitrite decreases sickle hemoglobin polymerization in vitro independently of methemoglobin formation.

[1]  K. Pajcini,et al.  Notch Signaling in the Bone Marrow Lymphopoietic Niche , 2021, Frontiers in Immunology.

[2]  M. Sperandio,et al.  Targeting Neutrophil Adhesive Events to Address Vaso-Occlusive Crisis in Sickle Cell Patients , 2021, Frontiers in Immunology.

[3]  Elizabeth Walek,et al.  Sickle cell disease subjects and mouse models have elevated nitrite and cGMP levels in blood compartments. , 2020, Nitric oxide : biology and chemistry.

[4]  M. Gladwin,et al.  Inorganic nitrite bioactivation and role in physiological signaling and therapeutics , 2019, Biological chemistry.

[5]  L. Netto,et al.  Impaired antioxidant capacity causes a disruption of metabolic homeostasis in sickle erythrocytes. , 2019, Free radical biology & medicine.

[6]  K. Nagaraju,et al.  The role of nitrite in muscle function, susceptibility to contraction injury, and fatigability in sickle cell mice. , 2018, Nitric oxide : biology and chemistry.

[7]  P. Buehler,et al.  Revisiting the putative role of heme as a trigger of inflammation , 2018, Pharmacology research & perspectives.

[8]  Elizabeth Walek,et al.  Blood collection vials and clinically used intravenous fluids contain significant amounts of nitrite☆ , 2017, Free radical biology & medicine.

[9]  W. Eaton,et al.  Treating sickle cell disease by targeting HbS polymerization. , 2017, Blood.

[10]  M. Gladwin,et al.  Potential therapeutic action of nitrite in sickle cell disease , 2017, Redox biology.

[11]  F. Piel,et al.  Sickle Cell Disease. , 2017, The New England journal of medicine.

[12]  R. Mahmood,et al.  Sodium nitrite enhances generation of reactive oxygen species that decrease antioxidant power and inhibit plasma membrane redox system of human erythrocytes , 2016, Cell biology international.

[13]  Z. Quezado,et al.  Cognitive and behavior deficits in sickle cell mice are associated with profound neuropathologic changes in hippocampus and cerebellum , 2016, Neurobiology of Disease.

[14]  Z. Quezado,et al.  Rapamycin increases fetal hemoglobin and ameliorates the nociception phenotype in sickle cell mice. , 2015, Blood Cells, Molecules & Diseases.

[15]  R. Mahmood,et al.  Sodium nitrite-induced oxidative stress causes membrane damage, protein oxidation, lipid peroxidation and alters major metabolic pathways in human erythrocytes. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  David L Streiner,et al.  Best (but oft-forgotten) practices: the multiple problems of multiplicity-whether and how to correct for many statistical tests. , 2015, The American journal of clinical nutrition.

[17]  Z. Quezado,et al.  Validation of a method to directly and specifically measure nitrite in biological matrices. , 2015, Nitric oxide.

[18]  A. Schechter,et al.  Inhibitory effect of nitrite on coagulation processes demonstrated by thrombelastography. , 2014, Nitric oxide : biology and chemistry.

[19]  A. Schechter,et al.  A Flow Cytometric Analysis of the Inhibition of Platelet Reactivity Due to Nitrite Reduction by Deoxygenated Erythrocytes , 2014, PloS one.

[20]  K. Rothman.  Six Persistent Research Misconceptions , 2014, Journal of general internal medicine.

[21]  A. Alayash,et al.  Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. , 2014, Blood.

[22]  S. Ofori-Acquah,et al.  Extracellular hemin crisis triggers acute chest syndrome in sickle mice. , 2013, The Journal of clinical investigation.

[23]  Asya Makhro,et al.  Red cell investigations: art and artefacts. , 2013, Blood reviews.

[24]  A. Schechter,et al.  Platelet Inhibition by Nitrite Is Dependent on Erythrocytes and Deoxygenation , 2012, PloS one.

[25]  K. Hassell.  Population estimates of sickle cell disease in the U.S. , 2010, American journal of preventive medicine.

[26]  A. Schechter,et al.  The Reaction between Nitrite and Oxyhemoglobin , 2008, Journal of Biological Chemistry.

[27]  Marius Wernig,et al.  Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin , 2007, Science.

[28]  R. Figueiredo,et al.  Characterization of Heme as Activator of Toll-like Receptor 4* , 2007, Journal of Biological Chemistry.

[29]  M. Gladwin,et al.  Deoxymyoglobin Is a Nitrite Reductase That Generates Nitric Oxide and Regulates Mitochondrial Respiration , 2007, Circulation research.

[30]  T. Townes,et al.  Correction of sickle cell disease by homologous recombination in embryonic stem cells. , 2006, Blood.

[31]  S. Ballas,et al.  Aggregation of normal and sickle hemoglobin in high concentration phosphate buffer. , 2004, Biophysical journal.

[32]  N. Bryan,et al.  Bound NO in human red blood cells: fact or artifact? , 2004, Nitric oxide : biology and chemistry.

[33]  M. Gladwin,et al.  Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation , 2003, Nature Medicine.

[34]  J. E. Russell,et al.  A high-throughput microplate method for assessing aggregation of deoxygenated hemoglobin s heterotetramers in vitro. , 2002, Analytical biochemistry.

[35]  R. Stevens,et al.  Responses of normal and sickle cell hemoglobin to S-nitroscysteine: implications for therapeutic applications of NO in treatment of sickle cell disease. , 2002, Biophysical chemistry.

[36]  R. Melnick,et al.  Pharmacokinetics of sodium nitrite-induced methemoglobinemia in the rat. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[37]  M. López-Rivadulla,et al.  Determination of methemoglobin and total hemoglobin in toxicological studies by derivative spectrophotometry. , 2002, Journal of analytical toxicology.

[38]  C. E. Cobb,et al.  Nitrite uptake and metabolism and oxidant stress in human erythrocytes. , 2000, American journal of physiology. Cell physiology.

[39]  L. Pannell,et al.  Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes. , 2000, Biochemical and biophysical research communications.

[40]  M. Gladwin,et al.  Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Bryszewska,et al.  Membrane effects of nitrite-induced oxidation of human red blood cells. , 1999, Biochimica et biophysica acta.

[42]  C. Bonaventura,et al.  Effects of S-Nitrosation on Oxygen Binding by Normal and Sickle Cell Hemoglobin* , 1999, The Journal of Biological Chemistry.

[43]  O. Platt,et al.  Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.

[44]  K. Tanaka,et al.  Impaired erythrocyte methemoglobin reduction in sickle cell disease: dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content. , 1990, Blood.

[45]  B. Lubin,et al.  Mechanism of inhibition of sickling by dimethyl adipimidate. Effects of intertetramer cross-linking. , 1984, Biochimica et biophysica acta.

[46]  K. Adachi,et al.  The solubility of sickle and non-sickle hemoglobins in concentrated phosphate buffer. , 1979, The Journal of biological chemistry.

[47]  E. Beutler,et al.  The removal of leukocytes and platelets from whole blood. , 1976, The Journal of laboratory and clinical medicine.

[48]  E. Beutler.  The effect of methemoglobin formation in sickle cell disease. , 1961, Journal of Clinical Investigation.

[49]  E. Beutler,et al.  The mechanism of removal of leukocytes by cellulose columns. , 1986, Blood cells.

[50]  K. Adachi,et al.  Kinetics of the polymerization of hemoglobin in high and low phosphate buffers. , 1982, Blood cells.

[51]  L. Packer,et al.  Dimethyl adipimidate: a new antisickling agent. , 1975, Proceedings of the National Academy of Sciences of the United States of America.